The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

The U.S. Food and Drug Administration (FDA) recently launched a drug repurposing initiative that may signal a shift in how ...

Google DeepMind’s Coscientist and Future House’s Robin use multi-agent AI systems to propose testable biomedical hypotheses ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

CSIR-IICT scientists have used AI-driven structural bioinformatics to identify a promising repurposed drug candidate against poxviruses, including Mpox and Lumpy Skin Disease Virus.

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

AI is no longer just for coding or drug discovery. Companies like L'Oréal, Mondelez, Nestlé and Haleon are using it to create ...

Mayo Clinic's AI Research Summit drew 750+ experts June 4-5 to explore decision-support AI, multi-agent systems and virtual ...

An examination of the trade secret risks posed by the integration of generative AI (GenAI) and agentic AI into core business ...

Drug-resistant infections are already killing patients, lengthening hospital stays, raising treatment costs and weakening the ...

India's Ministry of Health and Family Welfare has launched a set of digital health initiatives, including common data standards and patient- and provider-facing applications, to improve health data ...